参仙升脉口服液对频率依赖性早搏疗效观察

Shenxian Shengmai Oral Liquid in Treatment of Frequency-Dependent Premature

目的：探讨参仙升脉口服液对频率依赖性早搏的治疗效果。方法：5例频发室性早搏患者先常规给予胺碘酮或心律平口服2~4周,复查动态心电图,总心率减慢,早搏次数增加,患者症状加重,考虑为频率依赖性早搏后,给予参仙升脉口服液治疗2~4周,并进行动态心电图检查分析及患者自觉症状,不良反应观察。结果：动态心电图提示参仙升脉口服液可明显减少早搏次数,改善患者症状,未见明显不良反应。结论：参仙升脉口服液对治疗频率依赖性早搏有较好的疗效。

Objective ： To explore the treatment effect on frequency-dependent premature by using Shenxian Shengmai Oral Liquid. Methods ： 5 cases of frequency-dependent premature were treated with amiodarone for 2-4 weeks and then by measuring the dynamic electrocardiogram, it found the total heart rate rising and premature beats increasing, which meant the patients got worse symptoms. And then, the patients were with Shenxian Shengmai Oral Liquid for 2-4 weeks, re-examining the dynamic electrocardiogram and analyzing the patients subjective symptoms and observing the adverse reaction. Result ： Apparently dynamic electrocardiogram indicates that Shenxian Shengmai Oral Liquid can reduce the times of premature beats, improve the symptoms of the patients and there is no obvious adverse reactions. Conclusion：Shenxian Shengmai Oral Liquid is the better medicine for frequency-dependent premature.